Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Shares Outstanding (2016 - 2023)

Rapid Therapeutic Science Laboratories' Shares Outstanding history spans 7 years, with the latest figure at $8.8 million for Q2 2023.

  • For Q2 2023, Shares Outstanding rose 14.01% year-over-year to $8.8 million; the TTM value through Jun 2023 reached $8.8 million, up 14.01%, while the annual FY2022 figure was $7.8 million, 0.26% changed from the prior year.
  • Shares Outstanding for Q2 2023 was $8.8 million at Rapid Therapeutic Science Laboratories, up from $8.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $175.9 million in Q3 2020 and bottomed at $1.2 million in Q1 2019.
  • The 5-year median for Shares Outstanding is $7.7 million (2022), against an average of $41.5 million.
  • The largest annual shift saw Shares Outstanding surged 14508.15% in 2020 before it plummeted 96.0% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $156.9 million in 2019, then tumbled by 95.38% to $7.2 million in 2020, then rose by 6.96% to $7.7 million in 2021, then increased by 0.28% to $7.8 million in 2022, then grew by 13.75% to $8.8 million in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Shares Outstanding are $8.8 million (Q2 2023), $8.1 million (Q1 2023), and $7.8 million (Q4 2022).